Cell line · CVCL_1403
Papers39
1 to 20 of 39
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 43004984 | Yale J Biol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Reassessment of the roles of coronin proteins as actin effectors and in signaling. | PLoS Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SNAT1 (SLC38A1) Is Not the Main Glutamine Transporter in Melanoma, but Controls Metabolism via Glutamine-Dependent Activation of P62 (SQSTM1)/cMYC-Axis. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Emerging role of ARHGAP29 in melanoma cell phenotype switching. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mammalian and bacterial adaptors function as co-disinhibitory pairs to activate the E3 ubiquitin ligase WWP2. | J Biol Chem | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Acidic melanoma microenvironment selects for a senescence-like but also migratory-active subpopulation driving metastatic disease. | Cell Death Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Mitochondria regulate MR1 protein expression and produce self-metabolites that activate MR1-restricted T cells. | Proc Natl Acad Sci U S A | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Splicing control by PHF5A is crucial for melanoma cell survival. | Cell Prolif | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Chemical inhibition of the integrated stress response impairs the ubiquitin-proteasome system. | Commun Biol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Systems mapping of bidirectional endosomal transport through the crowded cell. | Curr Biol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients. | Mol Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma. | Cell Commun Signal | 2024 | Its Methods give the RRID and name the line | PubMed | |
| The β Isoform of Human ATP-Binding Cassette B5 Transporter, ABCB5β, Localizes to the Endoplasmic Reticulum. | Int J Mol Sci | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells. | iScience | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells. | Cancers (Basel) | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species. | Sci Adv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Cytosolic stress granules relieve the ubiquitin-proteasome system in the nuclear compartment. | EMBO J | 2023 | Its Methods give the RRID and name the line | PubMed | |
| A previously unknown Argonaute 2 variant positively modulates the viability of melanoma cells. | Cell Mol Life Sci | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1403/papers